Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial

Ítems similars

• The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
  per: Blomster, Juuso I, et al.
  Publicat: (2016)
• Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
  per: van Steen, Sigrid C., et al.
  Publicat: (2018)
• Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE trial
  per: Batty, G. David, et al.
  Publicat: (2010)
• Oral disease and cardiovascular disease in people with type 2 diabetes: prospective cohort study based on the ADVANCE trial
  per: Li, Qiang, et al.
  Publicat: (2010)
• PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study
  per: Hamet, Pavel, et al.
  Publicat: (2017)